JP2004521618A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004521618A5 JP2004521618A5 JP2002543671A JP2002543671A JP2004521618A5 JP 2004521618 A5 JP2004521618 A5 JP 2004521618A5 JP 2002543671 A JP2002543671 A JP 2002543671A JP 2002543671 A JP2002543671 A JP 2002543671A JP 2004521618 A5 JP2004521618 A5 JP 2004521618A5
- Authority
- JP
- Japan
- Prior art keywords
- allergen
- recombinant
- mutant
- amino acid
- naturally occurring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013566 allergen Substances 0.000 description 205
- 230000035772 mutation Effects 0.000 description 61
- 150000001413 amino acids Chemical class 0.000 description 40
- 229960004784 allergens Drugs 0.000 description 35
- 125000000539 amino acid group Chemical group 0.000 description 34
- 238000000034 method Methods 0.000 description 26
- 238000006467 substitution reaction Methods 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 21
- 241000894007 species Species 0.000 description 19
- 206010020751 Hypersensitivity Diseases 0.000 description 18
- 125000003275 alpha amino acid group Chemical group 0.000 description 17
- 239000000203 mixture Substances 0.000 description 17
- 239000002904 solvent Substances 0.000 description 15
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 12
- 108010061608 Dermatophagoides pteronyssinus antigen p 2 Proteins 0.000 description 11
- 210000001744 T-lymphocyte Anatomy 0.000 description 11
- 230000007815 allergy Effects 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 208000026935 allergic disease Diseases 0.000 description 10
- 230000028993 immune response Effects 0.000 description 10
- 102220570133 Histone PARylation factor 1_K32Q_mutation Human genes 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000008194 pharmaceutical composition Substances 0.000 description 9
- 102220286523 rs1554071538 Human genes 0.000 description 9
- 102220096864 rs876658354 Human genes 0.000 description 9
- 102220616965 Uncharacterized protein CLBA1_Y5V_mutation Human genes 0.000 description 8
- 238000004132 cross linking Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000000428 dust Substances 0.000 description 8
- 102220215242 rs1060500710 Human genes 0.000 description 8
- 238000002255 vaccination Methods 0.000 description 8
- 108010061629 Dermatophagoides pteronyssinus antigen p 1 Proteins 0.000 description 7
- 102220534042 Angiopoietin-related protein 3_K65N_mutation Human genes 0.000 description 6
- 102220509819 General transcription factor II-I_K15E_mutation Human genes 0.000 description 6
- 102100025656 Keratin, type II cytoskeletal 6A Human genes 0.000 description 6
- 102220553625 Lens fiber major intrinsic protein_E42S_mutation Human genes 0.000 description 6
- 102220539290 Programmed cell death 1 ligand 2_E62S_mutation Human genes 0.000 description 6
- 102220483118 TLC domain-containing protein 4_H30N_mutation Human genes 0.000 description 6
- 210000003719 b-lymphocyte Anatomy 0.000 description 6
- 235000008216 herbs Nutrition 0.000 description 6
- 229960001340 histamine Drugs 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 102220487951 Isoaspartyl peptidase/L-asparaginase_R145E_mutation Human genes 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 210000003630 histaminocyte Anatomy 0.000 description 5
- 239000013573 pollen allergen Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 102220267544 rs1555225967 Human genes 0.000 description 5
- 102220072212 rs772406363 Human genes 0.000 description 5
- 238000002741 site-directed mutagenesis Methods 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 241000256837 Apidae Species 0.000 description 4
- 241001674044 Blattodea Species 0.000 description 4
- 241000257303 Hymenoptera Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- WYGWHHGCAGTUCH-ISLYRVAYSA-N V-65 Substances CC(C)CC(C)(C#N)\N=N\C(C)(C#N)CC(C)C WYGWHHGCAGTUCH-ISLYRVAYSA-N 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 235000018185 Betula X alpestris Nutrition 0.000 description 3
- 235000018212 Betula X uliginosa Nutrition 0.000 description 3
- 241000219495 Betulaceae Species 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241000726768 Carpinus Species 0.000 description 3
- 235000001543 Corylus americana Nutrition 0.000 description 3
- 235000007466 Corylus avellana Nutrition 0.000 description 3
- 241000238710 Dermatophagoides Species 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 102220470904 Interferon-induced protein with tetratricopeptide repeats 5_K48E_mutation Human genes 0.000 description 3
- 102220558262 Ras association domain-containing protein 1_S24N_mutation Human genes 0.000 description 3
- 241000256856 Vespidae Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000004121 copper complexes of chlorophylls and chlorophyllins Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000004174 erythrosine Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000004177 patent blue V Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000013615 primer Substances 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 102200011389 rs121908121 Human genes 0.000 description 3
- 102220005546 rs34273731 Human genes 0.000 description 3
- 102220082323 rs35269563 Human genes 0.000 description 3
- 102220044712 rs373563053 Human genes 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000004149 tartrazine Substances 0.000 description 3
- 241000238876 Acari Species 0.000 description 2
- 206010027654 Allergic conditions Diseases 0.000 description 2
- 102220465445 Angiogenin_Q36A_mutation Human genes 0.000 description 2
- 241000208837 Asterales Species 0.000 description 2
- 102220519232 Casein kinase I isoform gamma-2_V2F_mutation Human genes 0.000 description 2
- 241000723382 Corylus Species 0.000 description 2
- 240000007582 Corylus avellana Species 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 108010055622 Dermatophagoides farinae antigen f 1 Proteins 0.000 description 2
- 108010082995 Dermatophagoides farinae antigen f 2 Proteins 0.000 description 2
- 102220526133 Dihydrofolate reductase_Q36K_mutation Human genes 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000795633 Olea <sea slug> Species 0.000 description 2
- 241001536628 Poales Species 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102220616378 Rhombotin-1_D72H_mutation Human genes 0.000 description 2
- 102220474458 Ribitol-5-phosphate xylosyltransferase 1_D72N_mutation Human genes 0.000 description 2
- 102220487957 S-formylglutathione hydrolase_S149T_mutation Human genes 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000003651 basophil Anatomy 0.000 description 2
- 102220355148 c.260A>G Human genes 0.000 description 2
- 102220368494 c.4G>A Human genes 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000002983 circular dichroism Methods 0.000 description 2
- 210000001728 clone cell Anatomy 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102200081514 rs1060503420 Human genes 0.000 description 2
- 102220058215 rs202168814 Human genes 0.000 description 2
- 102220005188 rs33958358 Human genes 0.000 description 2
- 102220005275 rs33958358 Human genes 0.000 description 2
- 102220074134 rs760435152 Human genes 0.000 description 2
- 102200086277 rs775019409 Human genes 0.000 description 2
- 102220060547 rs786203080 Human genes 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 102220598613 5-hydroxytryptamine receptor 1E_K29A_mutation Human genes 0.000 description 1
- 241000219496 Alnus Species 0.000 description 1
- 241000223600 Alternaria Species 0.000 description 1
- 241000796533 Arna Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000219429 Betula Species 0.000 description 1
- 235000003932 Betula Nutrition 0.000 description 1
- 241000219430 Betula pendula Species 0.000 description 1
- 241000238657 Blattella germanica Species 0.000 description 1
- 241000339490 Brachyachne Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000281762 Chenopodium ambrosioides Species 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 235000005490 Chenopodium botrys Nutrition 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 241000209210 Dactylis Species 0.000 description 1
- 241000238713 Dermatophagoides farinae Species 0.000 description 1
- 241000238740 Dermatophagoides pteronyssinus Species 0.000 description 1
- 102220516781 Dynein light chain 1, cytoplasmic_T67A_mutation Human genes 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000219427 Fagales Species 0.000 description 1
- 102220516017 Fractalkine_K78A_mutation Human genes 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000009438 IgE Receptors Human genes 0.000 description 1
- 108010073816 IgE Receptors Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102220619547 L-lactate dehydrogenase B chain_T10P_mutation Human genes 0.000 description 1
- 241001510164 Lepidoglyphus destructor Species 0.000 description 1
- 241000209082 Lolium Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000238675 Periplaneta americana Species 0.000 description 1
- 102220487745 Protein eyes shut homolog_D25N_mutation Human genes 0.000 description 1
- 241000238711 Pyroglyphidae Species 0.000 description 1
- 102220481680 Rap guanine nucleotide exchange factor 3_A16P_mutation Human genes 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000220221 Rosales Species 0.000 description 1
- 230000006052 T cell proliferation Effects 0.000 description 1
- 206010045240 Type I hypersensitivity Diseases 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 102200115877 c.165G>T Human genes 0.000 description 1
- 102220348510 c.458C>G Human genes 0.000 description 1
- 239000005482 chemotactic factor Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000000222 eosinocyte Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229940046533 house dust mites Drugs 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 102200063015 rs137852850 Human genes 0.000 description 1
- 102220054671 rs145551875 Human genes 0.000 description 1
- 102220051042 rs727505209 Human genes 0.000 description 1
- 102220009776 rs80358500 Human genes 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000005090 tracheal smooth muscle Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24936100P | 2000-11-16 | 2000-11-16 | |
| DKPA200001718 | 2000-11-16 | ||
| US29817001P | 2001-06-14 | 2001-06-14 | |
| PCT/DK2001/000764 WO2002040676A2 (en) | 2000-11-16 | 2001-11-16 | Mutant allergens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004521618A JP2004521618A (ja) | 2004-07-22 |
| JP2004521618A5 true JP2004521618A5 (enExample) | 2006-02-09 |
Family
ID=27222455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002543671A Pending JP2004521618A (ja) | 2000-11-16 | 2001-11-16 | 新規変異体アレルゲン |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1373510B1 (enExample) |
| JP (1) | JP2004521618A (enExample) |
| KR (1) | KR100919914B1 (enExample) |
| CN (1) | CN100577804C (enExample) |
| AT (1) | ATE414773T1 (enExample) |
| AU (2) | AU2350502A (enExample) |
| CA (1) | CA2429172C (enExample) |
| CZ (1) | CZ20031653A3 (enExample) |
| DE (1) | DE60136653D1 (enExample) |
| DK (1) | DK1373510T3 (enExample) |
| ES (1) | ES2317955T3 (enExample) |
| HU (1) | HUP0302601A3 (enExample) |
| MX (1) | MXPA03004174A (enExample) |
| NO (1) | NO329721B1 (enExample) |
| NZ (1) | NZ525820A (enExample) |
| PL (1) | PL214225B1 (enExample) |
| WO (1) | WO2002040676A2 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020051794A1 (en) | 2000-08-09 | 2002-05-02 | Alk-Abello A/S | Novel parenteral vaccine formulations and uses thereof |
| EP1504089A2 (en) * | 2002-05-16 | 2005-02-09 | Alk Abell A/S | Allergen mutants |
| FR2841906B1 (fr) * | 2002-07-05 | 2006-08-18 | Stallergenes Sa | Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes |
| JP2006520184A (ja) | 2002-11-01 | 2006-09-07 | アルカベロ アクチェセルスカプ | 組換えタンパク質変種 |
| WO2004047793A1 (en) | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Pharmaceutical allergen product |
| CA2516291C (en) | 2003-02-28 | 2012-02-14 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| JP4782671B2 (ja) * | 2003-06-04 | 2011-09-28 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 低減したアレルギー誘発性および保持されたＴ細胞反応性を有するＰｈｌｐ５ａ誘導体 |
| EP2272502A1 (en) | 2003-12-19 | 2011-01-12 | Alk-Abelló A/S | Cryogranules of a liquid composition of an allergen product |
| CN102657863A (zh) * | 2003-12-19 | 2012-09-12 | 爱尔开-阿贝优公司 | 用于活性药剂的低温制粒和贮藏的方法 |
| EP1756150A2 (en) * | 2004-04-23 | 2007-02-28 | Novozymes A/S | Group 1 mite polypeptide variants |
| US20060115499A1 (en) * | 2004-09-27 | 2006-06-01 | Alk-Abello A/S | Liquid allergy vaccine formulation for oromucosal administration |
| US20060121063A1 (en) * | 2004-10-22 | 2006-06-08 | Novozymes A/S | Group 2 mite polypeptide variants |
| ES2424229T3 (es) | 2005-03-18 | 2013-09-30 | Cytos Biotechnology Ag | Proteínas de fusión de alérgenos de gato y utilización de las mismas |
| EP2324850A1 (en) | 2005-10-04 | 2011-05-25 | Alk-Abelló A/S | Solid vaccine formulation |
| DK1814516T3 (da) * | 2005-11-04 | 2013-03-25 | Alk Abello As | Anvendelse af en flydende allergivaccineformulering til oromucosal indgivelse |
| CA2628226A1 (en) * | 2005-11-04 | 2007-05-10 | Alk-Abello A/S | Use of a liquid allergy vaccine formulation for oromucosal administration |
| ITMI20052517A1 (it) * | 2005-12-29 | 2007-06-30 | Lofarma Spa | Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa |
| AT503297B1 (de) * | 2006-05-18 | 2007-09-15 | Biomay Ag | Allergen-spezifische antikörper |
| AT503690A1 (de) | 2006-06-09 | 2007-12-15 | Biomay Ag | Hypoallergene moleküle |
| EP1908777B1 (en) * | 2006-10-06 | 2016-02-03 | Stallergenes | Mite fusion proteins |
| EP1974746B1 (en) | 2007-03-28 | 2012-01-11 | Alk-Abelló A/S | Use of an adjuvanted allergy vaccine formulation for parenteral administration |
| BRPI0815395A2 (pt) | 2007-08-15 | 2015-02-10 | Circassia Ltd | Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição. |
| DE202008006598U1 (de) | 2008-04-11 | 2008-10-02 | Alk-Abelló A/S | Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung |
| WO2010146171A1 (en) | 2009-06-19 | 2010-12-23 | Alk-Abelló A/S | Novel manner of administering allergen in allergen specific immunotherapy |
| CA2786936A1 (en) | 2010-01-14 | 2011-07-21 | Merck Patent Gmbh | Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues |
| EP2388268A1 (en) * | 2010-05-18 | 2011-11-23 | Stallergenes S.A. | Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes |
| FI20115374A0 (fi) | 2011-04-18 | 2011-04-18 | Teknologian Tutkimuskeskus Vtt Oy | Uudet hypoallergeenit |
| FI20115375A0 (fi) | 2011-04-18 | 2011-04-18 | Teknologian Tutkimuskeskus Vtt Oy | Uudet hypoallergeenit |
| ITMI20112301A1 (it) * | 2011-12-19 | 2013-06-20 | Lofarma Spa | Varianti ipoallergeniche dell'allergene maggiore phl p 5 di phleum pratense |
| EP2692732A1 (en) | 2012-08-03 | 2014-02-05 | Stallergenes S.A. | Novel allergen from ragweed pollen and uses thereof |
| NZ707615A (en) | 2012-10-30 | 2019-01-25 | Aravax Pty Ltd | Novel immunotherapeutic molecules and uses thereof |
| JP6300907B2 (ja) * | 2013-06-06 | 2018-03-28 | アネルギ エスアー | イエダニアレルギーの処置のための連続したオーバーラップペプチド |
| EP3050040A2 (en) | 2013-09-24 | 2016-08-03 | Fibar Group S.A. | Intelligent smoke sensor |
| WO2015042664A1 (en) | 2013-09-25 | 2015-04-02 | Monash University | Novel immunotherapeutic composition and uses thereof |
| EP2952200A1 (en) | 2014-06-04 | 2015-12-09 | Alk-Abelló A/S | Allergen for prophylactic treatment of allergy |
| US9898175B2 (en) | 2014-08-05 | 2018-02-20 | Fibar Group S.A. | Home network manager for home automation |
| EP3269730A1 (en) * | 2016-07-12 | 2018-01-17 | Universität Salzburg | Allergen variant |
| EP3625332B1 (en) * | 2017-05-19 | 2022-02-02 | F. Hoffmann-La Roche AG | Method for the production of thymocyte supernatant |
| CN110093336B (zh) * | 2018-01-29 | 2023-03-24 | 上海雅心生物技术有限公司 | 一种稳定的胰蛋白酶及其制备方法 |
| RU2761431C9 (ru) | 2020-10-26 | 2022-04-18 | Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) | Рекомбинантный полипептид на основе аллергена пыльцы березы и аллергена яблока в качестве вакцины от аллергии |
| JP2025520496A (ja) * | 2022-06-17 | 2025-07-03 | ダンマルクス テクニスケ ウニベルシテット | コンセンサスアレルゲンに基づくアレルギーワクチン |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1874997A (en) * | 1996-02-15 | 1997-09-02 | Pangenetics B.V. | Molecules for the induction of immunological tolerance |
| DE19713001A1 (de) * | 1997-03-27 | 1998-10-01 | Merck Patent Gmbh | Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung |
| CA2319437C (en) * | 1998-01-31 | 2009-06-16 | University Of Arkansas | Methods and reagents for decreasing allergic reactions |
| AU749749B2 (en) * | 1998-03-16 | 2002-07-04 | Alk-Abello A/S | Mutant recombinant allergens |
-
2001
- 2001-11-16 PL PL362273A patent/PL214225B1/pl not_active IP Right Cessation
- 2001-11-16 EP EP01996610A patent/EP1373510B1/en not_active Expired - Lifetime
- 2001-11-16 HU HU0302601A patent/HUP0302601A3/hu unknown
- 2001-11-16 MX MXPA03004174A patent/MXPA03004174A/es active IP Right Grant
- 2001-11-16 NZ NZ525820A patent/NZ525820A/en not_active IP Right Cessation
- 2001-11-16 ES ES01996610T patent/ES2317955T3/es not_active Expired - Lifetime
- 2001-11-16 CZ CZ20031653A patent/CZ20031653A3/cs unknown
- 2001-11-16 AU AU2350502A patent/AU2350502A/xx active Pending
- 2001-11-16 DE DE60136653T patent/DE60136653D1/de not_active Expired - Lifetime
- 2001-11-16 JP JP2002543671A patent/JP2004521618A/ja active Pending
- 2001-11-16 DK DK01996610T patent/DK1373510T3/da active
- 2001-11-16 AT AT01996610T patent/ATE414773T1/de active
- 2001-11-16 CN CN01820783A patent/CN100577804C/zh not_active Expired - Fee Related
- 2001-11-16 AU AU2002223505A patent/AU2002223505B2/en not_active Ceased
- 2001-11-16 CA CA2429172A patent/CA2429172C/en not_active Expired - Fee Related
- 2001-11-16 KR KR1020037006644A patent/KR100919914B1/ko not_active Expired - Fee Related
- 2001-11-16 WO PCT/DK2001/000764 patent/WO2002040676A2/en not_active Ceased
-
2003
- 2003-05-15 NO NO20032213A patent/NO329721B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2317955T3 (es) | Alergenos mutantes. | |
| ES2313776T3 (es) | Alergenos recombinantes mutantes. | |
| AU2002223505A1 (en) | Mutant allergens | |
| Saarne et al. | Rational design of hypoallergens applied to the major cat allergen Fel d 1 | |
| US20090148466A1 (en) | Process for the Preparation of Hypoallergenic Mosaic Antigens | |
| US20090054625A1 (en) | Recombinant protein variants | |
| PT2397154E (pt) | Péptidos para dessensibilização contra alergénios | |
| PL212139B1 (pl) | Zrekombinowany alergen, zastosowanie zrekombinowanego alergenu, kompozycja zawierająca dwa lub więcej wariantów zrekombinowanych zmutowanych alergenów, zastosowanie takiej kompozycji, kompozycja farmaceutyczna zawierająca zrekombinowany alergen lub wymienioną kompozycję, zastosowanie zrekombinowanego alergenu, kompozycji lub kompozycji farmaceutycznej, sposób przygotowania kompozycji farmaceutycznej, sposób przygotowania zrekombinowanego alergenu, sposób przygotowania biblioteki zrekombinowanego alergenu, sekwencja DNA kodująca zrekombinowany alergen, wektor ekspresyjny obejmujący wymienione DNA, komórka gospodarza zawierająca taki wektor ekspresyjny, sposób produkcji zrekombinowanego mutanta alergenu, oraz oznaczenie diagnostyczne do oceny odpowiedniości, bezpieczeństwa lub wyniku terapii | |
| Vrtala et al. | Genetic engineering of the major timothy grass pollen allergen, Phl p 6, to reduce allergenic activity and preserve immunogenicity | |
| US6335020B1 (en) | Allergenic peptides from ragweed pollen | |
| RU2285042C2 (ru) | Новые мутантные аллергены | |
| US20030175312A1 (en) | Novel mutant allergens | |
| JP2001518451A (ja) | アレルゲンの非アナフィラキシー形およびその使用 | |
| ZA200303667B (en) | Novel mutant allergens. | |
| HK1060371B (en) | Mutant allergens | |
| HK1152729A (en) | Recombinant protein variants | |
| EP1558740A2 (en) | Recombinant protein variants |